Rush Institutional Biosafety Committee Meeting Minutes
The Institutional Biosafety Committee reviewed several new applications for research involving recombinant DNA, viral vectors, and mouse models, resulting in provisional approvals contingent on meeting specific safety, training, and documentation requirements. The committee also acknowledged the review of prior business updates regarding various ongoing research applications. No new business, incident reports, or public comments were reported during the session.